Science Explorer Back to mapMap
Discussion
Researcher · AbbVie (United States) · United States

Yan Luo

Yan Luo publishes mostly in Oncology, Surgery and Epidemiology, on topics such as PARP inhibition in cancer therapy, Hepatitis C virus research and DNA Repair Mechanisms.

ORCID 0000-0002-4793-253X OpenAlex
World rank
#1,675,155
of 7,710,434 ranked researchers
Rank in United States
#518,754
of 1,627,098
Works
95
Citations
3.2k
Citations per work
33.3
h-index
24
i10-index 34Top 17% in Oncology
Yan Luo

What does Yan Luo research?

Yan Luo's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (8%).

Everything else: 54 works · 57.2% of their workHealth Sciences: 33 works · 35.1% of their workMedicine: 33 works · 35.1% of their workOncology: 11 works · 11.9% of their workEpidemiology: 8 works · 8.0% of their workSurgery: 8 works · 8.0% of their workHepatology: 4 works · 3.8% of their workInfectious Diseases: 3 works · 3.4% of their workLife Sciences: 7 works · 7.7% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 7.7% of their workMolecular Biology: 7 works · 7.7% of their workTHEIR WORKYan Luo95works
Life Sciences8%Health Sciences35%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else5457.2%
    1. Medicine3335.1%
    1. Biochemistry, Genetics and Molecular Biology77.7%
  1. 1Oncology12% of their works
  2. 2Surgery8% of their works
  3. 3Epidemiology8% of their works
  4. 4Molecular Biology8% of their works
  5. 5Hepatology4% of their works
  6. 6Infectious Diseases3% of their works

Research topics

Which keywords describe Yan Luo's research?

The keywords of their largest research topics: Homologous Recombination, BRCA Mutation, PARP Inhibitors, Antiviral Therapy, Liver Disease, Chemotherapy, Mortality and Hepatitis C Virus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Homologous Recombination212 topics
  2. BRCA Mutation151 topic
  3. PARP Inhibitors151 topic
  4. Antiviral Therapy132 topics
  5. Liver Disease132 topics
  6. Chemotherapy102 topics
  7. Mortality102 topics
  8. Hepatitis C Virus81 topic
  9. Treatment81 topic
  10. DNA Damage61 topic
  11. Repair61 topic
  12. Cardiac Risk51 topic
  13. Chronic Hepatitis B51 topic
  14. DNA51 topic
  15. Genomic Profiles51 topic
  16. Hepatitis B Virus51 topic
  17. Hip Fracture51 topic
  18. Perioperative51 topic
  19. Small-Cell Lung Cancer51 topic
  20. Surgery51 topic
  21. Topoisomerases51 topic

Where does Yan Luo work?

Yan Luo's main affiliation in the publication record is AbbVie (United States), United States.

How many publications and citations does Yan Luo have?

OpenAlex counts 95 works and 3,163 citations for Yan Luo, an h-index of 24, ranking #1,675,155 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Yan Luo

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yan Luo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.